Literature DB >> 14607676

Influence of portal pressure change on intestinal permeability in patients with portal hypertension.

Wei-Hua Xu1, Xing-Jiang Wu, Jie-Shou Li.   

Abstract

OBJECTIVE: To investigate intestinal permeability in patients with portal hypertension and its relationship with portal pressure.
METHODS: Twenty patients with portal hypertension were divided into two groups (A, B), 10 patients per group. In group A, patients were treated with combined transjugular intrahepatic portosystemic shunt (TIPS) and modified Sugiura. In group B, patients were treated with modified Sugiura only. Intestinal permeability was assessed before operation, two weeks after TIPS, and two weeks after modified Sugiura; 20 healthy control subjects were also assessed.
RESULTS: Intestinal permeability was significantly higher in the patients than in the control group (P<0.01). In group A, portal pressure, intestinal permeability decreased two weeks after TIPS (P<0.05), and no obvious change was noted two weeks after modified Sugiura; but they were significantly lower than those before TIPS (P<0.05). In group B, intestinal permeability was not different before and after operation. Intestinal permeability in group A was not different from that in group B before treatment, but significantly lower after modified Sugiura (P<0.05). Portal pressure was significantly correlated with intestinal permeability (r=0.627, P<0.01).
CONCLUSIONS: This study shows that combined TIPS and modified Sugiura can lower portal pressure and intestinal permeability, and enhance the therapeutic efficacy on portal hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 14607676

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  8 in total

1.  Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore.

Authors:  Yu Jun Wong; Rajamanickam Chandrasekaran Kalki; Kenneth Weicong Lin; Rahul Kumar; Jessica Tan; Eng Kiong Teo; James Weiquan Li; Tiing Leong Ang
Journal:  Singapore Med J       Date:  2019-07-30       Impact factor: 1.858

Review 2.  Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.

Authors:  Gaurav Ghosh; Arun B Jesudian
Journal:  J Clin Exp Hepatol       Date:  2018-08-27

Review 3.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 4.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

Review 5.  Gut microbiota and inflammation.

Authors:  Asa Hakansson; Goran Molin
Journal:  Nutrients       Date:  2011-06-03       Impact factor: 5.717

6.  The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

Authors:  Daniel Benten; Julian Schulze zur Wiesch; Karsten Sydow; Andreas Koops; Peter Buggisch; Rainer H Böger; Charlotte A Gaydos; Helen Won; Veronica Franco; Ansgar W Lohse; Stuart C Ray; Ashwin Balagopal
Journal:  BMC Gastroenterol       Date:  2011-10-06       Impact factor: 3.067

Review 7.  Intestinal permeability in a patient with liver cirrhosis.

Authors:  Jonathan Manuel Aguirre Valadez; Liliana Rivera-Espinosa; Osvely Méndez-Guerrero; Juan Luis Chávez-Pacheco; Ignacio García Juárez; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

8.  Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.

Authors:  Kosuke Kaji; Soichiro Saikawa; Hiroaki Takaya; Yukihisa Fujinaga; Masanori Furukawa; Koh Kitagawa; Takahiro Ozutsumi; Daisuke Kaya; Yuki Tsuji; Yasuhiko Sawada; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Antibiotics (Basel)       Date:  2020-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.